3 Stocks in the Cannabis Sector Worth Considering: CBD Life Sciences (CBDL), CBD of Denver, Inc. (CBDD) and Marijuana Company of America (MCOA)

During the runup to the 2020 election, now President Joe Biden pledged to decriminalize marijuana. Although it was a tad bit short of full legalization, the overture was well received by proponents of both personal liberties and marijuana stocks. Further, with the Biden administration having the benefit of Democratic control of Congress (albeit a tenuous one), the future looks bright for botanicals.

At the same time, investors need to be realistic about cannabis stocks. Yes, the legislative backdrop continues to support the concept of legalization, with even conservative states warming up to acceptance of the plant to various degrees or conditions. Yet the marijuana investment market hasn’t been the most stable, irrespective of the encouraging ecosystem.

This is why prospective buyers who are bullish on cannabis stocks should consider companies that offer a diversified take on the industry. These include companies that offer traditional cannabis-based solutions but other products as well. And they might not even be marijuana firms at all but provide necessary services for the industry. 

Spring is here in the Northern Hemisphere — and that means many gardeners and farmers have planting on their minds. For investors wanting to join the party and do some planting of cash in stocks, 3 stocks in the cannabis sector worth considering are CBD Life Sciences (OTC: CBDL), CBD of Denver, Inc. (OTC: CBDD) and Marijuana Company of America (OTC: MCOA)

CBD Life Sciences (OTC: CBDL)’s main focus is to identify, evaluate and acquire undervalued opportunities with the objective of increasing shareholder value. The acquisition of LBC Bioscience Inc. is the first in the CBD space and the company is actively searching for additional opportunities within this emerging sector.

LBC Bioscience Inc. is a wholly owned subsidiary of CBD Life Sciences Inc. LBC has developed and is retailing/wholesaling a full line of cannabidiol based organic products including CBD drops, pain relief creams, anxiety and sleep supplements, CBD brain boost coffee, weight loss coffee, gummies, a full line of CBD infused anti – aging skincare line and a full pet line including Hemp for horses.

CBD Life Sciences through its wholly owned subsidiary, LBC Bioscience Inc. President & CEO, Lisa Nelson recently announced its all new Delta-10 Cartridges.

CBD Life Sciences Inc. is working with two different strains of Delta-10 Cartridges. The two strains are Sour Diesel & Blue Dream, and both are 900MG for each one. President & CEO, Lisa Nelson states “This will be a great addition to our product line since we already have a variety of products as it is including Delta-8 & Delta 9.” Lisa Nelson also states “We’ve been selling thousands of Delta-8 products a day. And based on the feedback from Delta-10 so far, we are ramping production to prepare for a similarly soaring demand. We think Delta-8 and Delta-10 have the power to turn the CBD market on its head.” This is going to be a premiere product for CBD Life Sciences Inc. online distribution coming in the near term while the company has 3 upcoming trade shows.

Delta-10 THC is one of the hundreds of cannabinoids you can find in hemp and cannabis. While very little research has been done on its mechanism of action in the body, Delta-10 THC likely interacts with the endocannabinoid system in a similar way as other THC compounds. Delta-9 THC and Delta-8 THC have binding affinities towards CB1 receptors in the brain and nervous system, which produce varying levels of psychotropic effects. Delta-10 may interact similarly with CB1 receptors at high concentrations. People don’t just want CBD for its natural wellness benefits. They want something to take the edge off. They want to feel noticeably more relaxed, and they don’t want to have to get a medical cannabis card to do it. For these self-helpers, CBD alone isn’t always enough.

Last month, the company also announced that it is entering the Kosher Market. The products they are going to start working with are CBD Gummies, CBD Mints, Chamomile & CBD Enriched Tea, and CBD Horse Chews! 

President & CEO Lisa Nelson states, “We have a ton of customers demanding kosher products, and by doing this, it fulfills the current customer’s needs on top of giving us access to an avenue of all new customers all around the world”! “This will also bring in a significant amount of revenue along with overall more sales globally as well.”

Kosher certification is a standalone international quality standard that is increasingly prevalent in the food ingredients and retail sector. Walk into any supermarket in North America or Europe, and you will see that a significant portion of the food and drink is certified kosher, from the coveted Mars Bar, Marmite, to McCain’s oven chips. In recent years demand for kosher certified products has increased dramatically. A quartz article, 2015, identified that less than 2% of the USA’s population is Jewish, yet 41% of the country’s packaged food is kosher. In 2009, the kosher industry was estimated to be worth around $17 billion, with an annual growth rate of around 15%, and in 2010 the New York Times claimed it was one of the hottest food trends.

LBC’s products can be viewed and purchased on the company website at www.lbcbioscienceinc.com.

CBD of Denver, Inc. (OTC: CBDD) a full-line CBD and Hemp oil company and a producer and distributor of Cannabis and CBD products in Switzerland, Europa and US. CBDD is focused on using equity to acquire profitable Swiss assets at attractive valuations to create value for all our shareholders driven by a passion to improve lives and strengthen communities by unleashing the full potential of cannabis.

CBD of Denver Inc recently provided its preliminary February 2021 revenue numbers showing strong sales volume despite the continuing pandemic-related lockdowns across Europe.

Marijuana Company of America (OTC: MCOA) is an emerging company and leader offering unique exposure to the global cannabis sector. The Company recently transitioned from research & development to a revenue-producing cannabis marketing company focused on sales & marketing of the Company’s line of proprietary botanical legal hemp-based CBD (cannabidiol) “hempSMART™” products.

hempSMART™ offers an extensive full line of premium CBD organic products that are scientifically driven and double lab tested to ensure purity and potency. The Company will direct the sale of its products to wholesalers, distributors, the medical community, online e-commerce consumer platforms, and a proven network affiliate marketing program. The Company has also launched international sales, production, and marketing expansion.

Marijuana Company of America recently announced that its wholly owned hempSMART™ subsidiary has entered into a non-exclusive logistics and distribution agreement with Fulfillment.com, an award-winning order fulfillment company serving high-volume national and global ecommerce brands.

Per the agreement, Fulfillment.com will provide best-in-class warehousing and logistics infrastructure needed for worldwide distribution of hempSMART’s premium cannabidiol (CBD) products. Fulfillment.com will initially target the United States, the UK and the Netherlands, where it has established customers and existing distribution channels for CBD products.

The evolving cannabis industry offers investors huge room for growth. The U.S. legal cannabis market, in particular, is set to boom. It could grow at a compound annual growth rate (CAGR) of 21% to be worth $41 billion by 2025, according to a report from New Frontier Data.

When it comes to investing, patience is key even when you’re investing in a quickly evolving industry like cannabis. 

Comments

LEAVE A REPLY

Please enter your comment!
Please enter your name here

FEATURED

Advertisment